Rivarp Medical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.27 M
as on 16-11-2024
- Revenue 148.06%
(FY 2023)
- Profit 156.61%
(FY 2023)
- Ebitda 118.87%
(FY 2023)
- Net Worth 123.38%
(FY 2023)
- Total Assets 67.38%
(FY 2023)
About Rivarp Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.27 M.
Mavidipalli Naidu, Arcot Rajanish, Mavidiapalli Karunakumari, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110KA2015PTC081433
- Company No.
081433
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rivarp Medical Private Limited offer?
Rivarp Medical Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Cylinder, Infusion Syringes & Supplies, Catheter, Forceps & Graspers, Surgical Equipments, Scalpels, Needles & Scissors, Surgical Needles, Industrial Pipe & Tube Fittings, Pipe Connectors.
Who are the key members and board of directors at Rivarp Medical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mavidipalli Naidu  | Director | 23-Oct-2017 | Current |
| Arcot Rajanish | Additional Director | 08-Feb-2020 | Current |
| Mavidiapalli Karunakumari | Director | 22-Feb-2018 | Current |
| Rajashekar Donthal | Director | 03-Jun-2020 | Current |
Financial Performance of Rivarp Medical.
Rivarp Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 148.06% increase. The company also saw a substantial improvement in profitability, with a 156.61% increase in profit. The company's net worth Soared by an impressive increase of 123.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rivarp Medical?
In 2023, Rivarp Medical had a promoter holding of 76.55% and a public holding of 23.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medical Bionic Private LimitedActive 21 years 9 monthsMavidipalli Naidu, Arcot Rajanish and 1 more are mutual person
Phoenix Medicare Private LimitedActive 26 years 2 monthsMavidipalli Naidu and Mavidiapalli Karunakumari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Apr 2022 | ₹7.27 M | Open |
How Many Employees Work at Rivarp Medical?
Rivarp Medical has a workforce of 46 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rivarp Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rivarp Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
